DiogenX Raises €4.5M in Seed Financing from Advent France Biotechnology, Boehringer Ingelheim Venture Fund and JDRF T1D Fund
Oncodesign establishes strategic alliance with HitGen to strengthen its Integrated Drug Discovery Service (IDDS)
Tollys closes Series A financing of €2.3 million
Accure Therapeutics launches with €7.6M Series A round
Minoryx Therapeutics doses first patient with leriglitazone in registration-enabling cALD NEXUS trial
Advanced BioDesign publishes its study in non-small cell lung cancer (NSCLC) in Oncogene
Domain Therapeutics receives development milestone payment from Merck KGaA, Darmstadt, Germany, for collaboration on adenosine receptor antagonists
Nosopharm obtains US patent for NOSO-502, a first-in-class novel antibiotic
